[EN] 1,3,5 -TRIAZINE-2-AMINE DERIVATIVES, PREPARATION THEREOF AND DIAGNOSTIC AND THERAPEUTIC USE THEREOF<br/>[FR] DÉRIVÉS DE 1,3,5-TRIAZINE-2-AMINE, PROCÉDÉ DE PRÉPARATION DE CEUX-CI ET UTILISATION DIAGNOSTIQUE ET THÉRAPEUTIQUE DE CES DÉRIVÉS
申请人:SANOFI SA
公开号:WO2013087643A1
公开(公告)日:2013-06-20
The present invention relates to compounds corresponding to formula (I) in which: - R1 represents a substituted phenyl; - R2 represents: - a substituted phenyl; - a heteroaromatic group, the said group being unsubstituted or substituted one or more times; - R3 represents a group Alk; - R4 represents a hydrogen atom or a (C1-C4)alkyl; - R5 represents a hydrogen atom, a (C3-C6)cycloalkyl or a (C1-C4)alkyl-O-Alk; - or alternatively R4 and R5, together with the nitrogen atom to which they are attached, constitute a heterocyclic radical chosen from: azetidin-1-yl, pyrrolidin-1-yl, piperid-1-yl, morpholin-4-yl; - R6 represents a group -COOAlk, a group -CONH 2 or a group -NHSO 2 Alk; - Alk represents a (C1-C4)alkyl, which is unsubstituted or substituted one or more times with a halogen atom; in the form of the base or of an acid-addition salt. Preparation process and diagnostic and therapeutic use.
本发明涉及与以下式(I)对应的化合物:- R1代表取代苯基;- R2代表:- 取代苯基;- 杂芳基团,所述基团未取代或取代一次或多次;- R3代表羟基烷基基团;- R4代表氢原子或(C1-C4)烷基;- R5代表氢原子,(C3-C6)环烷基或(C1-C4)烷基-O-烷基;- 或者R4和R5,连同它们连接的氮原子,构成从以下中选择的杂环基团:氮杂环丙烷-1-基,吡咯烷-1-基,哌啶-1-基,吗啉-4-基;- R6代表-羟基烷基基团,-酰胺基或-NHSO2烷基基团;- 烷基代表未取代或取代一次或多次的(C1-C4)烷基,其上带有卤原子;以碱或酸盐的形式。制备过程和诊断和治疗用途。